SCHEMBL6286074

SCHEMBL6286074

CC(=O)CCC(=O)CCc1ccccc1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.46
MAOA P21397 1/20 0.46
POLQ O75417 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
CNR1 P21554 1/20 0.42
ALDH1A1 P00352 3/20 0.42
LMNA P02545 1/20 0.42
IAPP P10997 1/20 0.41
GAA P10253 2/20 0.41
POLB P06746 1/20 0.41
EPHX2 P34913 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
DAO P14920 1/20 0.40
IDO1 P14902 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30257708 0.90 ALDH1A1 (0.50) MAOBMAOAPOLQHDAC1HDAC8
SCHEMBL266248 0.90 ALDH1A1 (0.50) MAOBMAOAPOLQHDAC1HDAC8
SCHEMBL7400128 0.90 HDAC1 (0.50) MAOBMAOAPOLQHDAC1HDAC8
SCHEMBL23662783 0.84 IAPP (0.53) MAOBMAOAPOLQHDAC1HDAC8
SCHEMBL24242035 0.82 ALOX5 (0.45) MAOBMAOAPOLQHDAC1HDAC8
SCHEMBL27872108 0.80 IDO1 (0.47) MAOBMAOAPOLQHDAC1HDAC8
SCHEMBL27860624 0.79 EPHX2 (0.51) POLQHDAC1HDAC8CNR1ALDH1A1
SCHEMBL29733422 0.78 EPHX2 (0.59) POLQHDAC1HDAC8CNR1ALDH1A1
SCHEMBL1953231 0.78 EPHX2 (0.59) POLQHDAC1HDAC8CNR1ALDH1A1
SCHEMBL8745933 0.78 HDAC1 (0.44) MAOBMAOAPOLQHDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6911468-B2 Tyrosine phosphatase inhibitors TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-06-28 US disclosed
US-20030144338-A1 Tyrosine phosphatase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-07-31 US disclosed
EP-1284260-A1 TYROSINE PHOSPHATASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2003-02-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144338-A1 Tyrosine phosphatase inhibitors PTPRC, PTPN1, PTPRM MAOB 2436/4885MAOA 2904/4885POLQ 3711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.